Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Xetra  >  Bayer    BAYN   DE000BAY0017

BAYER (BAYN)
Mes dernières consult.
Most popular
Report
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

Bayer : 520-18-1-233-0008-MedRad

share with twitter share with LinkedIn share with facebook
share via e-mail
0
10/03/2017 | 01:54pm CET

Document Type: Award Notice

Posted Date: 02-OCT-17

Location: Department of Veterans Affairs, VA Gulf Coast Veterans Health Care System, Department of Veterans Affairs Gulf Coast Veterans Health Care System

Classification Code: J - Maintenance, repair & rebuilding of equipment

Subject: 520-18-1-233-0008-MedRad

Solicitation Number: VA25617Q1137

Internet Link: https://www.fbo.gov/index?s=opportunity&mode=form&id=211473108a0fe6146b4fc51fd305a6c4&tab=documents&tabmode=list

Copyright (c) 2017 Federal Information & News Dispatch, Inc., source Federal Documents

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on BAYER
12/14 BAYER : Studies from Bayer Update Current Data on Nerve Tissue Proteins (A tripa..
12/13 BAYER : rivaroxaban submitted to U.S. FDA for approval in patients with coronary..
12/13DJPLANT IMPACT : Needs Extra GBP7 Million Funding by April, Hands up 'For Sale' Si..
12/12 Monsanto offers cash to U.S. farmers who use controversial chemical
12/08 EU regulators to warn Bayer about Monsanto bid
12/08 BAYER : Preventive Maintenance & service solution on existing Bayer/Medrad and A..
12/08 BAYER : J-- Preventive Maintenance & service solution on existing Bayer/Medrad a..
12/08 'Right steps' point to a healthier China
12/07 BAYER : Research Conducted at Bayer Has Provided New Information about Atrial Fi..
12/07 BAYER : Findings from Bayer Has Provided New Data on Liver Cancer (Exposure-resp..
More news
News from SeekingAlpha
12/14 3 THINGS IN BIOTECH YOU SHOULD LEARN : December 14, 2017
12/11 Buy Celgene And Regeneron On The Dips As Insiders Are Buying
12/08 BLOOMBERG : Bayer to face EU objections to Monsanto deal in coming days
12/07 COBAS ASSET MANAGEMENT : Comments On Third Quarter 2017
12/06 You Get A Dilution! You Get A Dilution! What About CRISPR Therapeutics?
Financials (€)
Sales 2017 35 698 M
EBIT 2017 7 647 M
Net income 2017 6 050 M
Debt 2017 8 890 M
Yield 2017 2,50%
P/E ratio 2017 13,85
P/E ratio 2018 18,11
EV / Sales 2017 2,68x
EV / Sales 2018 2,44x
Capitalization 86 912 M
Chart BAYER
Duration : Period :
Bayer Technical Analysis Chart | BAYN | DE000BAY0017 | 4-Traders
Technical analysis trends BAYER
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 27
Average target price 121 €
Spread / Average Target 15%
EPS Revisions
Managers
NameTitle
Werner Baumann Chairman-Management Board
Werner Wenning Chairman-Supervisory Board
Johannes M. Dietsch Chief Financial Officer
Katharina Jansen Head-Science & Research
Hartmut Klusik Head-Human Resources, Technology & Sustainability
Sector and Competitors
1st jan.Capitalization (M$)
BAYER6.02%102 422
JOHNSON & JOHNSON24.03%380 546
NOVARTIS13.16%222 673
PFIZER10.04%217 327
ROCHE HOLDING LTD.3.40%211 657
MERCK AND COMPANY-6.96%152 759